AR051826A1 - Composiciones inmunogenicas de antigenos polipeptidicos de staphylococcus epidermidis - Google Patents
Composiciones inmunogenicas de antigenos polipeptidicos de staphylococcus epidermidisInfo
- Publication number
- AR051826A1 AR051826A1 ARP050104384A ARP050104384A AR051826A1 AR 051826 A1 AR051826 A1 AR 051826A1 AR P050104384 A ARP050104384 A AR P050104384A AR P050104384 A ARP050104384 A AR P050104384A AR 051826 A1 AR051826 A1 AR 051826A1
- Authority
- AR
- Argentina
- Prior art keywords
- staphylococcus epidermidis
- immunogenic compositions
- refers
- polypeptides
- polypeptidic
- Prior art date
Links
- 241000191963 Staphylococcus epidermidis Species 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000002163 immunogen Effects 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
- G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62078804P | 2004-10-21 | 2004-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051826A1 true AR051826A1 (es) | 2007-02-14 |
Family
ID=37595601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104384A AR051826A1 (es) | 2004-10-21 | 2005-10-20 | Composiciones inmunogenicas de antigenos polipeptidicos de staphylococcus epidermidis |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8445000B2 (https=) |
| EP (4) | EP2298341A3 (https=) |
| JP (2) | JP2008517918A (https=) |
| KR (1) | KR20070068455A (https=) |
| CN (1) | CN101175508A (https=) |
| AR (1) | AR051826A1 (https=) |
| AU (1) | AU2005333603A1 (https=) |
| BR (1) | BRPI0516974A (https=) |
| CA (1) | CA2583121A1 (https=) |
| IL (1) | IL182546A0 (https=) |
| TW (1) | TW200619228A (https=) |
| WO (1) | WO2007001423A2 (https=) |
| ZA (1) | ZA200703274B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2468803B (en) * | 2005-05-19 | 2011-01-19 | Exocyte Ltd | Screening methods for bacterial killing |
| MX2011010735A (es) * | 2009-04-14 | 2012-01-25 | Novartis Ag | Composiciones para inmunizacion contra staphylococcus aureus. |
| HUE036372T2 (hu) | 2009-06-22 | 2018-07-30 | Wyeth Llc | Staphylococcus aureus antigének immunogén készítményei |
| EP2473630B1 (en) * | 2009-09-04 | 2017-11-08 | QIAGEN GmbH | Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci |
| SG10201605512WA (en) | 2011-07-06 | 2016-09-29 | Novartis Ag | Oil-in-water emulsions that contain nucleic acids |
| CA2840965C (en) | 2011-07-06 | 2021-03-02 | Novartis Ag | Cationic oil-in-water emulsions |
| US20150202277A1 (en) * | 2012-08-31 | 2015-07-23 | Novartis Ag | Stabilised proteins for immunising against staphylococcus aureus |
| BE1022857A1 (fr) * | 2014-03-26 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Immunisation contre staphylococcus aureus |
| SG11201901483QA (en) * | 2016-10-21 | 2019-03-28 | Socpra Sciences Et Genie Sec | Vaccine constructs and uses thereof against staphylococcus infections |
| KR102838831B1 (ko) * | 2019-01-30 | 2025-07-25 | 후지필름 일렉트로닉 머티리얼스 유.에스.에이., 아이엔씨. | 컨테이너 및 이의 제조 방법 |
| KR102627009B1 (ko) * | 2021-12-17 | 2024-01-19 | (주)메디톡스 | 피부 유해 세균에 대한 항세균 활성을 갖는 세균 균주, 및 이를 포함하는 약제학적 조성물 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| US4837151A (en) | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| DE122007000007I1 (de) | 1986-04-09 | 2007-05-16 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
| DE69233012T2 (de) * | 1991-11-22 | 2003-11-06 | Fattom, Ali Ibrahim | Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i |
| US5769047A (en) | 1991-12-23 | 1998-06-23 | Zoche; Michael | Engine with oil separator |
| DK0635132T4 (da) | 1992-03-19 | 2008-08-25 | Jackson H M Found Military Med | Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| AU675702B2 (en) * | 1993-01-26 | 1997-02-13 | Leslie R. Coney | Compositions and methods for delivery of genetic material |
| US6995008B1 (en) * | 1994-03-07 | 2006-02-07 | Merck & Co., Inc. | Coordinate in vivo gene expression |
| IL112820A0 (en) * | 1994-03-07 | 1995-05-26 | Merck & Co Inc | Coordinate in vivo gene expression |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| WO1996009321A1 (en) * | 1994-09-21 | 1996-03-28 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| JPH11514870A (ja) * | 1995-10-16 | 1999-12-21 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 新規な唾液結合タンパク質 |
| US6168918B1 (en) | 1996-01-31 | 2001-01-02 | American Home Products Corp. | Method of detecting foreign DNA integrated in eukaryotic chromosomes |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US7060458B1 (en) * | 1997-08-14 | 2006-06-13 | Wyeth | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| EP1117772B1 (en) | 1998-08-31 | 2012-10-24 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | Polypeptides and polynucleotides from coagulase-negative staphylococci |
| ATE378066T1 (de) | 1998-09-30 | 2007-11-15 | Wyeth Corp | Mutiertes cholera holotoxin als hilfsmittel |
| AU1478301A (en) | 1999-11-09 | 2001-06-06 | Glaxo Group Limited | Staphylococcus epidermidis nucleic acids and proteins |
| US6703492B1 (en) * | 1999-11-09 | 2004-03-09 | Smithkline Beecham Corporation | Staphylococcus epidermidis nucleic acids and proteins |
| GB0014907D0 (en) | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| US20020169288A1 (en) * | 2001-03-15 | 2002-11-14 | Magnus Hook | Collagen-binding adhesin from staphylococcus epidermidis and method of use |
| KR100898648B1 (ko) | 2001-06-07 | 2009-05-22 | 와이어쓰 홀딩스 코포레이션 | 보조제로서 콜레라 홀로톡신의 돌연변이체 형태 |
| CA2449670A1 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| EP1412379B1 (en) * | 2001-08-02 | 2012-01-25 | The University Of Sheffield | Vaccine |
| WO2004043405A2 (en) * | 2002-11-12 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
| US20060251675A1 (en) | 2003-03-17 | 2006-11-09 | Michael Hagen | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| DE602004024179D1 (de) | 2003-03-31 | 2009-12-31 | Intercell Ag | Staphylococcus epidermidis antigene |
| KR20070058631A (ko) | 2004-09-22 | 2007-06-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| EP2336323A3 (en) | 2005-03-25 | 2012-05-23 | National Research Council Of Canada | Method for isolation of soluble polypeptides |
-
2005
- 2005-10-19 US US11/665,940 patent/US8445000B2/en not_active Expired - Fee Related
- 2005-10-19 EP EP10182797A patent/EP2298341A3/en not_active Withdrawn
- 2005-10-19 WO PCT/US2005/037746 patent/WO2007001423A2/en not_active Ceased
- 2005-10-19 EP EP10182802A patent/EP2340848A3/en not_active Withdrawn
- 2005-10-19 BR BRPI0516974-7A patent/BRPI0516974A/pt not_active IP Right Cessation
- 2005-10-19 CN CNA2005800360186A patent/CN101175508A/zh active Pending
- 2005-10-19 TW TW094136450A patent/TW200619228A/zh unknown
- 2005-10-19 KR KR1020077011032A patent/KR20070068455A/ko not_active Withdrawn
- 2005-10-19 EP EP09008910A patent/EP2213298A3/en not_active Withdrawn
- 2005-10-19 JP JP2007538033A patent/JP2008517918A/ja active Pending
- 2005-10-19 AU AU2005333603A patent/AU2005333603A1/en not_active Abandoned
- 2005-10-19 CA CA002583121A patent/CA2583121A1/en not_active Abandoned
- 2005-10-19 EP EP05858253A patent/EP1802335A2/en not_active Withdrawn
- 2005-10-20 AR ARP050104384A patent/AR051826A1/es unknown
-
2007
- 2007-04-12 IL IL182546A patent/IL182546A0/en unknown
- 2007-04-20 ZA ZA200703274A patent/ZA200703274B/xx unknown
-
2013
- 2013-02-06 JP JP2013021337A patent/JP2013121981A/ja active Pending
- 2013-04-19 US US13/866,288 patent/US20130209501A1/en not_active Abandoned
-
2015
- 2015-03-31 US US14/674,512 patent/US20150196629A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2298341A3 (en) | 2011-07-13 |
| CA2583121A1 (en) | 2007-01-04 |
| US20150196629A1 (en) | 2015-07-16 |
| EP2213298A3 (en) | 2011-07-20 |
| IL182546A0 (en) | 2008-12-29 |
| KR20070068455A (ko) | 2007-06-29 |
| CN101175508A (zh) | 2008-05-07 |
| AU2005333603A1 (en) | 2007-01-04 |
| WO2007001423A2 (en) | 2007-01-04 |
| ZA200703274B (en) | 2008-06-25 |
| US20070292450A1 (en) | 2007-12-20 |
| EP2340848A2 (en) | 2011-07-06 |
| US20130209501A1 (en) | 2013-08-15 |
| US8445000B2 (en) | 2013-05-21 |
| TW200619228A (en) | 2006-06-16 |
| BRPI0516974A (pt) | 2008-09-30 |
| EP2298341A2 (en) | 2011-03-23 |
| JP2008517918A (ja) | 2008-05-29 |
| EP1802335A2 (en) | 2007-07-04 |
| WO2007001423A3 (en) | 2007-11-15 |
| EP2213298A2 (en) | 2010-08-04 |
| JP2013121981A (ja) | 2013-06-20 |
| EP2340848A3 (en) | 2011-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6440592A2 (es) | Composiciones para inmunizacion contra staphylococcus aureus | |
| GT200800132A (es) | Anticuerpos anti-il-23 humanos, composiciones, metodos y usos | |
| AR061246A1 (es) | Anticuerpos anti- dill4 y metodos que los usan | |
| BR0309492A (pt) | Uso de pelo menos um álcool ramificado alcoxilado | |
| CY1122911T1 (el) | ΑΝΟΣΟΘΕΡΑΠΕΙΑ ΜΕ ΤΗ ΧΡΗΣΗ ΚΥΤΤΑΡΟΥ ΤΟ ΟΠΟΙΟ ΕΧΕΙ ΤΗΝ ΙΚΑΝΟΤΗΤΑ ΣΥΝΕΚΦΡΑΣΗΣ ΑΝΤΙΓΟΝΟΥ ΣΤΟΧΟΥ ΚΑΙ CD1d ΚΑΙ ΕΙΝΑΙ ΔΙΕΓΕΡΜΕΝΟ ΜΕ ΣΥΝΔΕΤΗ CD1d | |
| AR057237A1 (es) | Metodos y composiciones para actuar sobre la poliubiquitina | |
| BRPI0708344B8 (pt) | vetores adenovirais quiméricos e composição imunogênica | |
| ECSP077888A (es) | Anticuerpos anti-il-6, composiciones, metodos y usos | |
| ECSP088831A (es) | Anticuerpos anti-tat226 e inmunoconjugados | |
| CL2006000880A1 (es) | Composicion inmunogena para causar una respuesta inmunologica contra una especie helicobacter y circovirus porcino que comprende antigenos de dichos patogenos; metodo para inducir una respuesta inmunologica contra dichos patogenos; kit para preparar la composicion inmunogena. | |
| AR051826A1 (es) | Composiciones inmunogenicas de antigenos polipeptidicos de staphylococcus epidermidis | |
| DK2468300T3 (da) | Vaccinesammensætning indeholdende syntetisk adjuvant | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| HN2011000357A (es) | Composiciones y metodos para anticuerpos que que se dirigen a la proteina de complemento c5 | |
| MX2007002787A (es) | Adyuvante de glicosilceramida para antigenos de sacarido. | |
| AR069552A1 (es) | Formulaciones para el tratamiento de semillas y metodos de uso | |
| BRPI0619795B8 (pt) | composição imunogênica, composição adjuvante, e, uso de uma composição imunogênica e um adjuvante | |
| BRPI0621181A8 (pt) | Substâncias imunogênicas que compreendem um adjuvante a base de ácido poliinosínico - ácido policitidílico | |
| AR063640A1 (es) | Anticuerpos agonistas de trkb y usos de los mismos | |
| CL2011002994A1 (es) | Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal. | |
| CR10280A (es) | Anticuerpos de la efgl7 y metodos de uso | |
| CL2019000019A1 (es) | Anticuerpos con baja inmunogenicidad y uso de los mismos | |
| WO2007052059A3 (en) | Changing th1/th2 balance in split influenza vaccines with adjuvants | |
| ECSP088675A (es) | Métodos y composiciones para actuar sobre relt | |
| NO20062579L (no) | Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |